Company: IPSC
Filing Date: 2025-12-09
Form Type: 8-K
Source: 0001104659-25-119494
Chunk: 0

Company: Century Therapeutics, Inc.
Filing Date: 2025-12-09
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01 Regulation FD Disclosure

On December 9, 2025, the Company issued a
press release announcing the appointments to the Board as discussed above. The full text of this press release is attached hereto as Exhibit 99.1
and is incorporated by reference herein. The information in this Item 7.01 and Exhibit 99.1 attached hereto is intended to be furnished
and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange
Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under
the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference to such filing.

  Item 9.01      Financial Statements and Exhibits  

(d) Exhibits

  Exhibit      Document                                                                     
     99.1      Press Release of Century Therapeutics, Inc., dated December 9, 2025          
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  CENTURY THERAPEUTICS, INC.                                             
  By:                             /s/ Brent Pfeiffenberger, PharmD, MBA  
  Name:                           Brent Pfeiffenberger, PharmD, MBA      
  Title:                          President and Chief Executive Officer  

Date: December 9, 2025